Pulmonary hypertension right heart catheterization: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:


==Right Heart Catheterization ==
==Right Heart Catheterization ==
*Right heart catheterization allows the determination of:<ref name="pmid26621978">{{cite journal |vauthors=Rosenkranz S, Preston IR |title=Right heart catheterisation: best practice and pitfalls in pulmonary hypertension |journal=Eur Respir Rev |volume=24 |issue=138 |pages=642–52 |date=December 2015 |pmid=26621978 |doi=10.1183/16000617.0062-2015 |url=}}</ref>  
*Right heart catheterization allows the determination of:<ref name="pmid26621978">{{cite journal |vauthors=Rosenkranz S, Preston IR |title=Right heart catheterisation: best practice and pitfalls in pulmonary hypertension |journal=Eur Respir Rev |volume=24 |issue=138 |pages=642–52 |date=December 2015 |pmid=26621978 |doi=10.1183/16000617.0062-2015 |url=}}</ref><ref name="pmid25163757">{{cite journal |vauthors=Guo X, Liu M, Ma Z, Wang S, Yang Y, Zhai Z, Wang C, Zhai R |title=Flow characteristics of the proximal pulmonary arteries and vena cava in patients with chronic thromboembolic pulmonary hypertension: correlation between 3.0 T phase-contrast MRI and right heart catheterization |journal=Diagn Interv Radiol |volume=20 |issue=5 |pages=414–20 |date=2014 |pmid=25163757 |pmc=4463330 |doi=10.5152/dir.2014.13501 |url=}}</ref><ref name="pmid25146706">{{cite journal |vauthors=Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D |title=Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population |journal=J Am Heart Assoc |volume=3 |issue=4 |pages= |date=August 2014 |pmid=25146706 |pmc=4310406 |doi=10.1161/JAHA.114.001103 |url=}}</ref><ref name="pmid23890907">{{cite journal |vauthors=D'Alto M, Romeo E, Argiento P, D'Andrea A, Vanderpool R, Correra A, Bossone E, Sarubbi B, Calabrò R, Russo MG, Naeije R |title=Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension |journal=Int. J. Cardiol. |volume=168 |issue=4 |pages=4058–62 |date=October 2013 |pmid=23890907 |doi=10.1016/j.ijcard.2013.07.005 |url=}}</ref><ref name="pmid17174196">{{cite journal |vauthors=Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S, Bremer HC, Baroke E, Rubin LJ |title=Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers |journal=J. Am. Coll. Cardiol. |volume=48 |issue=12 |pages=2546–52 |date=December 2006 |pmid=17174196 |doi=10.1016/j.jacc.2006.07.061 |url=}}</ref><ref name="pmid23260714">{{cite journal |vauthors=Taylor B, Rumbak M, Taylor SP, Solomon D |title=Early versus delayed right heart catheterization in evaluation of pulmonary arterial hypertension |journal=J. Heart Lung Transplant. |volume=32 |issue=1 |pages=137–8 |date=January 2013 |pmid=23260714 |doi=10.1016/j.healun.2012.10.004 |url=}}</ref>  
**Presence or absence of pulmonary hypertension, the underlying etiology, and the prognosis.
**Presence or absence of pulmonary hypertension, the underlying etiology, and the prognosis.
**Prognostic markers such as right atrial pressure, [[cardiac output]], and [[mean pulmonary artery pressure]].  
**Prognostic markers such as right atrial pressure, [[cardiac output]], and [[mean pulmonary artery pressure]].  

Revision as of 23:11, 2 March 2018

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension right heart catheterization On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension right heart catheterization

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension right heart catheterization

CDC on Pulmonary hypertension right heart catheterization

Pulmonary hypertension right heart catheterization in the news

Blogs on Pulmonary hypertension right heart catheterization

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension right heart catheterization

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-in-Chief: Ralph Matar; Rim Halaby

Overview

  • Cardiac catheterization is still the gold standard for diagnosing, assessing the severity, and determining the prognosis and response to therapy in pulmonary hypertension.
  • In the cardiac catheterization laboratory, inhaled nitric oxide is administered to determine if the pulmonary vasculature is still reactive or if the obstructionist fixed. It is dangerous to give nifedipine IV as a test because it could lead to a dangerous episode of hypotension.
  • This procedure has been shown to be safe, with no deaths reported in the NIH registry study. In addition, a recent study reported a procedure-related mortality of 0.055%.

Right Heart Catheterization

  • Right heart catheterization allows the determination of:[1][2][3][4][5][6]
    • Presence or absence of pulmonary hypertension, the underlying etiology, and the prognosis.
    • Prognostic markers such as right atrial pressure, cardiac output, and mean pulmonary artery pressure.
    • Pulmonary venous pressures by measuring pulmonary capillary wedge pressure (PCWP).
  • Fick’s method is reliable in patients with PAH for the measurement of cardiac output:

<figure-inline></figure-inline>

  • Since end-expiratory intrathoracic pressure most closely correlates with atmospheric pressure, it is important that all right ventricular, pulmonary artery, pulmonary wedge, and left ventricular pressures be measured at end-expiration.
  • The causes of pulmonary hypertension can be classified into three categories which are each characterized by different ranges of values recorded by right heart catherization.
    • Precapillary Pulmonary Hypertension (involving the pulmonary artery and arterioles)
      • PAH
      • Congenital heart diseases with Eisenmenger syndrome
      • Thromboembolism
    • Capillary PH
      • Parenchymal lung diseases
    • Post capillary PH (passive congestion that leads to elevated capillary wedge pressure)
      • Left heart failure
      • Mitral valve diseases
      • Pulmonary veno-occlusive diseases
  • Accordingly, the expected results by right heart catherization are:
    • Precapillary pulmonary hypertension
    • Postcapillary pulmonary hypertension
      • Mean Pulmonary artery pressure>25 mmHg
      • Capillary wedge pressure >15mmHg. If the pulmonary hypertension is due to left-sided heart failure, and the pulmonary artery diastolic pressure in the pulmonary capillary wedge pressure will be both similarly elevated.
      • Cardiac output: normal or low


<figure-inline></figure-inline> <figure-inline></figure-inline>

References

  1. Rosenkranz S, Preston IR (December 2015). "Right heart catheterisation: best practice and pitfalls in pulmonary hypertension". Eur Respir Rev. 24 (138): 642–52. doi:10.1183/16000617.0062-2015. PMID 26621978.
  2. Guo X, Liu M, Ma Z, Wang S, Yang Y, Zhai Z, Wang C, Zhai R (2014). "Flow characteristics of the proximal pulmonary arteries and vena cava in patients with chronic thromboembolic pulmonary hypertension: correlation between 3.0 T phase-contrast MRI and right heart catheterization". Diagn Interv Radiol. 20 (5): 414–20. doi:10.5152/dir.2014.13501. PMC 4463330. PMID 25163757.
  3. Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D (August 2014). "Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population". J Am Heart Assoc. 3 (4). doi:10.1161/JAHA.114.001103. PMC 4310406. PMID 25146706.
  4. D'Alto M, Romeo E, Argiento P, D'Andrea A, Vanderpool R, Correra A, Bossone E, Sarubbi B, Calabrò R, Russo MG, Naeije R (October 2013). "Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension". Int. J. Cardiol. 168 (4): 4058–62. doi:10.1016/j.ijcard.2013.07.005. PMID 23890907.
  5. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S, Bremer HC, Baroke E, Rubin LJ (December 2006). "Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers". J. Am. Coll. Cardiol. 48 (12): 2546–52. doi:10.1016/j.jacc.2006.07.061. PMID 17174196.
  6. Taylor B, Rumbak M, Taylor SP, Solomon D (January 2013). "Early versus delayed right heart catheterization in evaluation of pulmonary arterial hypertension". J. Heart Lung Transplant. 32 (1): 137–8. doi:10.1016/j.healun.2012.10.004. PMID 23260714.

Template:WikiDoc Sources